急性心肌梗死急诊经皮冠状动脉介入治疗后无复流现象的相关危险因素分析被引量：6

下载PDF

导出

摘要目的分析急性心肌梗死(AMI)急诊经皮冠状动脉介入治疗后无复流现象的相关危险因素。方法 80例急性心肌梗死患者,根据患者心肌梗死溶栓治疗临床试验(TIMI)血流情况分为无复流组和正常血流组,各40例。比较两组患者无复流的相关危险因素。结果无复流组的患者症状到再灌注的时间为(6.10±1.79)h、Q波计数为(3.54±0.79)个、TIMI血流0级15例、梗死前心绞痛8例、口服血管紧张素转化酶抑制剂(ACEI)等药物8例、Killip功能>Ⅱ级为12例,优于正常血流组的(3.78±1.65)h、(2.81±1.22)个、8例、19例、25例、5例,差异均具有统计学意义(P<0.05)。结论严重的心肌损伤、大面积心肌梗死、症状到再灌注时间较长和心功能不全均会形成术后无复流现象,是造成急性心肌梗死急诊经皮冠状动脉介入治疗后无复流的危险因素。

作者陈宇白保强李耀征李小红

机构地区驻马店市中心医院心血管内二科

出处《中国现代药物应用》 2016年第20期75-76,共2页 Chinese Journal of Modern Drug Application

关键词急性心肌梗死经皮冠状动脉介入治疗无复流

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献8

1于立鹏,杨志明.急性心肌梗死后缺血再灌注性心律失常发病机制及预防的研究进展[J].实用医学杂志,2016,32(9):1536-1537. 被引量：79
2胡彩贞,陈宗伟,唐玲玲,高阿妮.急性心肌梗死患者经皮冠状动脉成形术后BNP、hsCRP、cTnI浓度与预后的关系[J].中西医结合心脑血管病杂志,2015,13(13):1514-1516. 被引量：12
3徐家梁,蒋廷波.气温骤变期急性心肌梗死患者的临床特点及近期预后[J].浙江临床医学,2015,17(12):2127-2128. 被引量：3
4张庆成,汪承炜,梁桂娟,许文峰,韩晓丹,张向峰.急性心肌梗死心源性休克冠脉血栓抽吸并支架置入术的疗效及其安全性[J].武警医学,2015,26(8):765-767. 被引量：4
5周亚峰,姚佳璐,钱晓东,何志松,程绪杰,杨向军.急性心肌梗死患者急诊经皮冠状动脉成形术后低血压的相关因素分析[J].中华临床医师杂志（电子版）,2014,8(10):1-5. 被引量：11
6李森林.应用替罗非班在急性心肌梗死急诊经皮冠状动脉介入治疗及血栓抽吸术后疗效的观察.中国循环杂志,2014.29(z1):74.
7杨泽福,万建平,杨玲,薛世荣,汤群英.急性心肌梗死患者无复流现象与降低血浆胆固醇的临床观察[J].临床荟萃,2013,28(3):270-272. 被引量：3
8游琪.急性心肌梗死患者直接介入后无复流与血浆组织因子及组织因子途径抑制物的关系[J].现代中西医结合杂志,2015,24(5):463-465. 被引量：4

二级参考文献79

1李萍,熊凡,富青,杨莉,姚小卫,袁艇.参麦注射液对抗大鼠心肌缺血再灌注性心律失常作用[J].中国医院药学杂志,2005,25(9):815-817. 被引量：22
2李桂源主编.病理生理学[M].2版.北京:人民卫生出版社,2010:34-38.
3Ito H, Okamura A, Jwakura K, et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction[J]. Circulation, 1996, 93(11) : 1993-1999.
4Sakuma T,Hayasbi Y,Sumil K, et al. Prediction of short and intermediate term prognoses of acute myocardial infarction using contrast ochocardiography on day after recanalization [J]. J Am Coll Cardiol,1998,32(4) :890-897.
5Resnic FS, Wainstein M, Lee MK, et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention[J]. Am Heart J,2003,145 (1):42-46.
6Gibson CM, Cannon CP, Murphy SA, et al. Relationship of TIMI myocardial perfusion grade to mortality after of thrombolytic drugs administration [J]. Circulation, 2000, 101 (2) : 125-130,.
7Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction[J]. Circulation, 2002,105(16) : 1909-1913.
8Brosh D,Assali AR, Mager A,et al. Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality [J]. Am J Cardiol, 2007,99 (4) : 442-445.
9McLaughlin MG, Stone GW, Aymong E, et al. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardia} infaretiomthe Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial [J]. J Am Coll Cardiol,2004,44(6) :1215-1223.
10Galiuto L, Garramone B, Scara A, et al. The extent of microvascular damage during myocardial contrast echocardiography is guperior to other known indexes of post- infarct reperfusion in predicting left ventricular remodeling: results of the multieenter AMICI study[J]. J Am Coil Cardiol, 2008,51(5) :552-559.